Company intelligence
Julius Clinical
About Julius Clinical
P95 Julius Clinical is a global, science-led contract research organization (CRO) supporting clinical development from early-phase trials through late-phase and real-world evidence programs. The company specializes in complex research for biotech and pharmaceutical sponsors, with deep expertise across neuroscience, infectious diseases and vaccines, and cardiovascular, renal, and metabolic diseases. Backed by a leadership of scientific luminaries and more than 500 experts spanning five continents, P95 Julius Clinical combines the reach of a larger CRO with the agility of a mid-sized partner.
Verified activity
Signals from Julius Clinical
6 published signals
Presence & Recognition
Julius Clinical is attending the MASH Drug Development Summit 2026 in Boston.
Reported by Julius Clinical
People
Julius Clinical featured Director, Project Strategy and Delivery Larah de Groot in the latest installment of the Built Through Experience series.
Reported by Julius Clinical
Research & Knowledge
Julius Clinical published an article in the ESC2026 conference discussing how personalized prevention, nuanced benefit-risk assessment, cardiometabolic therapies, patient-centered trial design, EMR-supported recruitment, and advances in imaging and AI could shape future cardiovascular trials.
Reported by Julius Clinical
Research & Knowledge
Julius Clinical published an article examining how earlier use of real-world data supports more precise, practical, and executable development strategies for Parkinson's trials.
Reported by Julius Clinical
Presence & Recognition
Julius Clinical is attending the CNS Summit 2026 in Boston.
Reported by Julius Clinical
Presence & Recognition
Julius Clinical co-hosts the CNS Summit Theme Party with the theme Come as One of Your Heroes.
Reported by Julius Clinical